本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cartesian Therapeutics

6.57
-0.4200-6.01%
盘后:6.570.00000.00%19:30 EDT
成交量:21.86万
成交额:144.60万
市值:1.99亿
市盈率:-1.13
高:7.02
开:6.98
低:6.57
收:6.99
52周最高:11.00
52周最低:5.60
股本:3,025.54万
流通股本:1,240.27万
量比:1.57
换手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-5.7983
每股收益(LYR):-5.0200
净资产收益率:-7029.26%
总资产收益率:-17.43%
市净率:-1.59
市盈率(LYR):-1.31

数据加载中...

2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/08

重要事件披露

Form 8-K - Current report